Clinical effects of torasemide prolonged release in mild-to-moderate hypertension: A randomized noninferiority trial versus torasemide immediate release

Cardiovascular Therapeutics

Volumn 26, Issue 2, 2008, Pages 91-100

  Roca Cusachs, Alex ^a,g   Aracil Vilar, Joaquín ^b   Calvo Gómez, Carlos ^c   Vaquer Pérez, José Vicente ^d   Laporta Crespo, Félix ^e   Rojas Serrano, María José ^f   Guglietta, Antonio ^f   Gropper, Savion ^f   Alexeeva, Nadezhda ^h   Aranda, Pedro ⁱ   Ballvé, Josep Lluis ^j   Baranovsky, Andrei ^k   Boldueva, Svetlana ^l   Brotons, Carles ^m   Cano, Angel ⁿ   Churina, Svetlana ^o   Coca, Antoni ^p   De Teresa, Luis ^q   Divisón, Juan Antonio ^r   Dumpis, Yanis ^l   Farrés, Xavier ^s   Felip, Ángela ^t   García, Juan ^u   Gil, Blas ^v   Goloschekin, Boris ^w   Gómez, Pablo ^x   Kostenko, Victor ^y   De Coca, Enrique López ^z   Luque, Manuel ^aa   Marco, Emili ^ab   Martorell, Joan ^ac   Milyagin, Viktor ^ad   Orlov Morozov, Alexander ^ae   Parfenov, Vladimir ^af   Pavlysh, Elena ^ag   Plana, Jaume ^ah   Prieto, Miguel Ángel ^ai   Pujol, Montserrat ^aj   Rodríguez, José Carlos ^ak   Sherenkov, Alexander ^al   Sobrino, Javier ^am   Sorokin, Lev ^an   Vilà, Joaquim ^ao   Zobenko, Irina ^ap   Zrazhesvsky, Konstantin ^aq   more..

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Centro de Salud El Cristo   (Spain)

^c University Hospital of Santiago de Compostela   (Spain)

^d Centro de Salud Petrel   (Spain)

^e Centro de Salud La Roda   (Spain)

^f Ferrer Internacional SA   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h St Petersburg City Hospital 2   (Russian Federation)

ⁱ HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^j CAPS   (Spain)

^k St Petersburg City Hospital #31   (Russian Federation)

^l NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^m CAP Sardeña   (Spain)

ⁿ Laboratori Bon Pastor   (Spain)

^o Pokrovskaya Hospital   (Russian Federation)

^p UNIVERSITY OF BARCELONA   (Spain)

^q Hospital Sant Vicenç de Raspeig   (Spain)

^r CS de Fuentealbilla   (Spain)

^s CAP El Remei   (Spain)

^t HOSPITAL DE MATARÓ   (Spain)

^u HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^v HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^w St Petersburg City Hospital #15   (Russian Federation)

^x H Jerez de la Frontera   (Spain)

^y St Petersburg City Outpatient Unit #109   (Russian Federation)

^z CS Chinchilla   (Spain)

^aa HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^ab CAP Sarrià de Ter   (Spain)

^ac CS Guisona   (Spain)

^ad SMOLENSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^ae Moscow City Hospital #23   (Russian Federation)

^af Moscow City Hospital #61   (Russian Federation)

^ag St Petersburg City Outpatient Unit #25   (Russian Federation)

^ah Hospital Residencia San Camilo   (Spain)

^ai Centro de Salud Vallobin La Florida   (Spain)

^aj EAP El Carmel   (Spain)

^ak HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^al Krasnogvardeysky District Medical Physiology Clinic   (Russian Federation)

^am Hospital Esperit Sant   (Spain)

^an Great Martyr St Elizabeth City Hospital   (Russian Federation)

^ao Hospital Municipal de Badalona   (Spain)

^ap JSC Chernaya Rechka Health Center   (Russian Federation)

^aq St Petersburg Oncological City Hospital   (Russian Federation)

more..

Author keywords

Diuretic; Hypertension; Toresamide; Toresamide prolonged released

Indexed keywords

ANTIHYPERTENSIVE AGENT; SUTRIL; TORASEMIDE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ELECTROLYTE BLOOD LEVEL; EPISTAXIS; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; IMMEDIATE RELEASE FORMULATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROLONGED RELEASE FORMULATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT RESPONSE; URINARY URGENCY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DELAYED-ACTION PREPARATIONS; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPAIN; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME; URINATION;

EID: 46749098019     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2008.00046.x     Document Type: Article

References (19)

1. Baumgart P (1993) Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther 7 (Suppl 1 63 68.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ 2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289 : 2560 2572.
3. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E 2003) Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348 : 2407 2415.
4. Dunn CJ, Fitton A, Brogden RN (1995) Torasemide. An update of its pharmacological properties and therapeutic efficacy. Drugs 49 : 121 142.
5. European Society of Hypertension-European Society of Cardiology Guidelines Committee (2003) 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21 : 1011 1053.
6. Friedel HA, Buckley MMT (1991) Torasemide. A review of its pharmacological properties and therapeutic potential. Drugs 41 : 81 103.
7. Fukuda M, Kimura G (2006) Pathophysiology of antihypertensive therapy with diuretics. Hypertens Res 29 : 645 653.
8. Gifford RW Jr. (1984) The role of diuretics in the treatment of hypertension. Am J Med 77 : 102 106.
9. Gropper S, Albet C, Guglietta A, Antonijoan R, Gich I, Barbanoj MJ (2006a) Single-dose, randomized, cross-over bioavailability pilot clinical trial of torasemide immediate release compared to a new prolonged release formulation of torasemide [abstract]. Basic Clin Pharmacol Toxicol 99 (Suppl 1 48.
10. Gropper S, Rojas MJ, Guglietta A, Pelagio P, Antonijoan R, Gich I, Barbanoj MJ 2006b) Single and repeated-dose, randomized, cross-over, bioavailability clinical trial of torasemide immediate release compared to a new prolonged release formulation of torasemide [abstract]. Basic Clin Pharmacol Toxicol 99 (Suppl 1 48.
11. Krakoff LR (2005) Diuretics for hypertension. Circulation 112 : 127 129.
12. Luft FC (1993) Torasemide in the treatment of arterial hypertension. J Cardiovasc Pharmacol 22 (Suppl 3 S32 S39.
13. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al 2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25 : 1105 1187.
14. McVeigh GE, Flack J, Grimm R (1995) Goals of antihypertensive therapy. Drugs 49 : 161 175.
15. Salvetti A, Ghiadoni L (2006) Thiazide diuretics in the treatment of hypertension: An update. J Am Soc Nephrol 17 : S25 S29.
16. Staessen JA, Asmar R, De Buyzere M, Imai Y, Parati G, Shimada K, Stergiou G, Redon J, Verdecchia P 2001) Task Force II: Blood pressure measurement and cardiovascular outcome. Blood Press Monit 6 : 355 370.
17. The European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products (CPMP) (1999) Note for guidance on modified release oral and transdermal dosage forms: Section II (pharmacokinetic and clinical evaluation). CPMP/EWP/280/96 London.
18. Turbull F (2005) Managing cardiovascular risk factors: The gap between evidence and practice. PLoS Med 2 : e131.
19. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21 : 1983 1992.